Tag: acute myeloid leukemia

23-CNR-4419109-CQD-Hero-650×450 Dr Sauter
December 11, 2023/Research

Cell Therapy Offers New Hope for Refractory/Relapsed AML

Investigational chimeric antigen receptor natural killer cell therapy NKX101 associated with promising early response in patients with relapsed/refractory acute myeloid leukemia

23-CNR-4221120 ASH 2023 Graphics-CQD
December 4, 2023/Blood Cancers

Ten ASH Presentations You Don’t Want to Miss

Cleveland Clinic oncologists’ selected abstracts

23-CNR-4044609-CQD-Hero-650×450 AML study
October 20, 2023/Research

The Role of Immune Escape in Post-Transplant Leukemia Relapse

Immunological pressure driving genetic mutations

650×450-Child-Rural-Cancer
October 5, 2020/Cancer

Distance to Treatment Center Impacts Survival in Children and Young Adults With Acute Lymphoblastic Leukemia

Findings of a new study emphasize the importance of psychosocial support for patients and families

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

BackPage 1 of 1Next
Advertisement
Ad